Clinical value of TSH receptor antibodies measurement in patients with Graves' orbitopathy
. Pediatr Endocrinol Rev, 2010;7:198-203.
Tear film profile in patients with active thyroid orbitopathy
. Klin Oczna.
The body of clinical evidence with teprotumumab includes top-line positive results from the Phase 3 confirmatory clinical trial, called OPTIC (Treatment of Graves' Orbitopathy
(Thyroid Eye Disease) to Reduce Proptosis with Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study), presented at the 2019 American Association of Clinical Endocrinologists (AACE) meeting, as well as positive Phase 2 results.
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy
: a randomized controlled study.
(3) Smoking is also a risk factor for the development of several ocular pathologies such as age-related macular degeneration, ischemic optic neuropathy, hypertensive retinopathy, cataract, glaucoma, thyroid orbitopathy
, keratoconjunctivitis sicca, and strabismus in the offspring of smoking parents.
TED, also known as Graves' orbitopathy
(GO), affects approximately 25% of patients with Graves' disease and is influenced by gender with females being more at risk (approximately 5:1).
The results of the current study, however, are contrary to results of Altiparmak et al., 2012, as their study suggested that cyclosporine 0.05% with artificial tears drops is not more advantageous than artificial tears alone for the dry eye patients of thyroid orbitopathy
. The possible reason for these variations might be a different design, duration of the study and dose of cyclosporine and different the disease entity.
CT dimensions of the lacrimal gland in Graves orbitopathy
. Ophthalmic Plast.
After hosting a call featuring an expert focused on thyroid eye disease, also known as Graves' orbitopathy
, Piper Jaffray analyst David Amsellem reiterates an Overweight rating on Horizon Pharma with a $25 price target.
Patients with IgG4-ROD often present with painless bilateral orbitopathy
. The clinical symptoms are indolent and often occur as a result of regional mass effect or diffuse infiltration of involved tissues, including painless proptosis, diplopia, and impaired eye movements (40).
(TAO) is a common manifestation of Graves' disease.